Locanabio, Inc.

📍 San Diego, United States🗓 Founded 2016👥 65 employees💰 Last funded May 2019
Biotechnology Research🌐 locanabio.com
Website LinkedIn
At Locanabio, we are developing a new class of genetic medicines that has the potential to significantly improve the lives of patients with devastating genetic diseases by correcting the message of disease-causing RNA. Our proprietary platform uses gene therapy to deliver RNA-binding systems, including snRNA, Cas13d and PUF, that can be engineered to selectively manipulate disease-causing RNA by multiple mechanisms. Our systems are designed to provide a durable therapy with a single administration without altering a cell’s DNA. Locanabio’s platform has applications across a range of tissues and diseases, and we are currently advancing programs in rare genetic neuromuscular and neurodegenerative diseases. With world leadership in RNA biology and RNA-mediated disease and a top tier Board of Directors and panel of Scientific Advisors, we are poised to develop the next generation of genomic medicines for functional correction of disease.
2
Total investors
1
Early stage
1
Mid stage
0
Late stage
2016
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Belgium
1
United States
1
Frequently asked questions
Who invested in Locanabio, Inc.?
Locanabio, Inc. has 2 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage.
When did Locanabio, Inc. last raise funding?
The most recent investment in Locanabio, Inc. recorded on gritt.io was in May 2019.
When was Locanabio, Inc. founded?
Locanabio, Inc. was founded in 2016.
What industry is Locanabio, Inc. in?
Locanabio, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Locanabio, Inc. based?
Locanabio, Inc. is headquartered in San Diego, United States.